1. Home
  2. IREN vs PEN Comparison

IREN vs PEN Comparison

Compare IREN & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iris Energy Limited

IREN

Iris Energy Limited

HOLD

Current Price

$44.95

Market Cap

17.2B

Sector

Technology

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$336.43

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IREN
PEN
Founded
2018
2004
Country
Australia
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
13.2B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
IREN
PEN
Price
$44.95
$336.43
Analyst Decision
Buy
Buy
Analyst Count
11
17
Target Price
$64.60
$357.33
AVG Volume (30 Days)
24.4M
546.6K
Earning Date
04-27-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
234.48
1155.56
EPS
0.68
4.52
Revenue
$501,023,000.00
$1,403,665,000.00
Revenue This Year
$112.37
$14.20
Revenue Next Year
$168.33
$13.60
P/E Ratio
$61.13
$74.31
Revenue Growth
167.65
17.50
52 Week Low
$5.13
$221.26
52 Week High
$76.87
$362.41

Technical Indicators

Market Signals
Indicator
IREN
PEN
Relative Strength Index (RSI) 53.26 43.99
Support Level $37.37 $302.19
Resistance Level $48.52 $344.07
Average True Range (ATR) 2.83 2.35
MACD 0.55 -0.83
Stochastic Oscillator 77.43 21.27

Price Performance

Historical Comparison
IREN
PEN

About IREN Iris Energy Limited

IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy. Bitcoin mining operations generate revenue by earning Bitcoin through a combination of Block rewards and transaction fees from the operation of its Bitcoin miners and exchanging these Bitcoin for fiat currencies such as USD or CAD.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: